公司概述
Trupanion, Inc. operates as a provider of subscription-based medical insurance specifically designed for cats and dogs, serving pet owners and veterinarians across the United States, Canada, Continental Europe, and Australia. The company is classified within the Financial Services sector and more specifically within the Insurance - Property & Casualty industry, reflecting its core function of managing risk and premiums related to pet healthcare. This entity maintains a substantial scale with a market capitalization of $1.11 billion, an annual revenue of $1.44 billion over the trailing twelve months, and an employee base of 1121 individuals. These valuation and revenue figures indicate that Trupanion has established a significant market footprint, positioning it as a notable player in the pet insurance landscape with sufficient capitalization to support its operational expansion and service delivery across multiple international jurisdictions.
财务健康
The company reported a revenue of $1.44 billion, net income of $19.43 million, and EBITDA of $31.11 million for the trailing twelve months, highlighting a substantial disparity between top-line growth and bottom-line profitability. The gap between the $1.44 billion revenue and the $19.43 million net income reveals a cost structure where operating expenses, likely driven by claims payments and acquisition costs, consume a significant portion of generated income before reaching the net profit line. Free cash flow stands at -$23,275,000, indicating that the company is currently burning cash, which suggests limited immediate financial flexibility for share buybacks or heavy capital expenditures without external financing. In terms of profitability efficiency, the gross margin is 22.6%, the operating margin is 2.2%, and the profit margin is 1.4%, levels that indicate high operational leverage and sensitivity to minor fluctuations in claim ratios or underwriting costs. The balance sheet shows $370.73 million in cash against $125.95 million in debt, resulting in a debt-to-equity ratio of 32.80, which presents a leveraged profile where the company carries significant debt relative to its equity base. Despite the leverage, the current ratio of 1.67 indicates a comfortable liquidity position, meaning the company holds sufficient current assets to cover its short-term liabilities with a 1.67-to-1 margin. Return on equity is 5.5% and return on assets is 1.1%, metrics that reveal management effectiveness is constrained by the high cost of capital and the low overall return generated on the asset base.
估值评估
The stock carries a trailing P/E ratio of 57.04 compared to a forward P/E of 6.04, a stark difference that implies the market is pricing in a dramatic and rapid expansion of future earnings relative to current performance. The price-to-book ratio is 2.90, indicating that the market values the company at nearly three times its net asset book value, suggesting a significant premium attached to its intangible assets and brand moat in the pet insurance space. Alternative valuation metrics such as a price-to-sales ratio of 0.77 and an EV/EBITDA of 27.97 suggest that the market is willing to pay a substantial multiple of sales and earnings, reflecting confidence in the sustainability of its recurring revenue model. The 52-week high is $57.88 and the 52-week low is $24.32, providing a range of $33.56 in absolute terms to assess the current trading environment. While the exact current price is not provided in the facts, the beta value of 1.66 indicates that the stock exhibits 66% higher volatility than the broader market, meaning price swings are amplified compared to large-cap financial indices.
Growth & Income
Revenue growth is recorded at 11.7% year-over-year while earnings growth surges to 235.1%, demonstrating that profitability is expanding at a rate far exceeding top-line revenue growth, which often signals improving loss ratios or operational efficiency gains. As a non-dividend payer, the company reports a dividend yield of N/A and a payout ratio of 0.0%, indicating that all net income is retained within the business to fund operations, debt reduction, or future growth initiatives rather than being distributed to shareholders. The divergence between the 11.7% revenue increase and the 235.1% earnings increase highlights a period of aggressive margin expansion where the company is generating significantly more profit per dollar of sales than in prior periods. Overall, the growth and income profile is characterized by high earnings elasticity and zero dividend distribution, prioritizing capital retention for internal reinvestment over immediate shareholder income returns.